|
1
|
Zhou ZP and Yang RC: Rituximab treatment
for chronic refractory idiopathic thrombocytopenic purpura.
Hematology. 65:21–31. 2008.
|
|
2
|
George JN, Woolf SH and Raskob GE: ITP:
practice guideline developed by explicit methods for the American
Society of Hematology. Blood. 88:3–40. 1996.PubMed/NCBI
|
|
3
|
Beardsley DS and Ertem M: Platelet
autoantibodies in immune thrombocytopenic purpura. Transfus Sci.
9:237–244. 1998. View Article : Google Scholar
|
|
4
|
Kuwana M, Okazaki Y, Kaburaki J and Ikeda
Y: Detection of circulating B cells secreting platelet-specific
autoantibody is useful in the diagnosis of autoimmune
thrombocytopenia. Am J Med. 114:322–325. 2003. View Article : Google Scholar
|
|
5
|
British Committee for Standards in
Haematology. General Haematology Task Force: Guidelines for the
investigation and management of idiopathic thrombocytopenic purpura
in adults, children and in pregnancy. Br J Haematol. 120:574–596.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cines DB and McMillan R: Management of
adult idiopathic thrombocytopenic purpura. Annu Rev Med.
56:425–442. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meletis J, Katsandris A, Raptis S and
Mantzourani M: Successful treatment of immune thrombocytopenic
purpura (ITP) with the thrombopoietin-mimetic romiplostim. Med Sci
Monit. 16:100–102. 2010.PubMed/NCBI
|
|
8
|
Kojouri and George JN: Recent advances in
the treatment of chronic refractory immune thrombocytopenic
purpura. Int J Hematol. 81:119–125. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pierik M, Rutgeerts P, Vlietinck R and
Vermeire S: Pharmacogenetics in inflammatory bowel disease. World J
Gastroenterol. 12:3657–3667. 2006.PubMed/NCBI
|
|
10
|
Nair SC, Rimerman RA, Toran EJ, Chen S,
Prapapanich V and Butts RN: Molecular cloning of human FKBP51 and
comparisons of immunophilin interactions with Hsp90 and
progesterone receptor. Mol Cell Biol. 17:594–603. 1997.PubMed/NCBI
|
|
11
|
Binder EB: The role of FKBP5, a
co-chaperone of the glucocorticoid receptor in the pathogenesis and
therapy of affective and anxiety disorders.
Psychoneuroendocrinology. 34:186–195. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vermeer H, Hendricks-Stegemann BAI, Van
der Burg B, van Buul Offers SC and Jansen M: Glucocorticoid-induced
increase in lymphocytic FKBP5 messenger ribonucleic acid
expression: a potential marker for glucocorticoid sensitivity,
potency, and bioavailability. J Clin Endocrin Metabol. 88:277–284.
2003. View Article : Google Scholar
|
|
13
|
Wochnik GM, Ruegg J, Abel GA, Schmidt U,
Holsboer F and Rein T: FK506-binding proteins 51 and 52
differentially regulate dynein interaction and nuclear
translocation of the glucocorticoid receptor in mammalian cells. J
Biol Chem. 28:4609–4616. 2005. View Article : Google Scholar
|
|
14
|
Binder EB, Salyakina D, Lichtner P,
Wochnik GM, Ising M, Putz B, et al: Polymorphisms in FKBP5 are
associated with increased recurrence of depressive episodes and
rapid response to antidepressant treatment. Nat Gen. 36:1319–1325.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tatro ET, Everall IP, Masliah E, Hult BJ,
Lucero G and Chana G: Differential expression of immunophilins
FKBP51 and FKBP52 in the frontal cortex of HIV-infected patients
with major depressive disorder. J Neuroimmune Pharmacol. 4:218–226.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Woodruff PG, Boushey HA, Dolganov GM,
Barker CS, Yang YH, Donnelly S, et al: Genome-wide profiling
identifies epithelial cell genes associated with asthma and with
treatment response to corticosteroids. Proc Natl Acad Sci USA.
104:15858–15863. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shibuya N, Suzuki A, Sadahiro R, Kamata M,
Matsumoto Y, Goto K, Hozumi Y and Otani K: Association study
between a functional polymorphism of FK506-binding protein 51
(FKBP5) gene and personality traits in healthy subjects. Neurosci
Lett. 485:194–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maltese P, Palma L, Sfara C, Rocco PD,
Latiano A, Palmieri O, Corritore G, Annese V and Magnani M:
Glucocorticoid resistance in Crohn's disease and ulcerative
colitis: an association study investigating GR and FKBP5 gene
polymorphisms. Pharmacogenomics. 26:1–7. 2011.
|
|
19
|
Scammell JG, Denny WB, Valentine DL and
Smith DF: Overexpression of the FK506-binding immunophilin FKBP51
is the common cause of glucocorticord resistance in three New World
primates. Gen Comp Endocrinol. 124:152–165. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hubler TR and Scammell JG: Intronic
hormone response elements mediate regulation of FKBP5 by progestins
and glucocorticoids. Cell Stress Chaperones. 9:243–252. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ising M, Depping AM, Siebertz A, Lucae S,
Unschuld PG, Kloibers S, Horstmann S, Uhr M, Müller-Myhsok B and
Holsboer F: Polymorphisms in the FKBP5 gene region modulate
recovery from psychosocial stress in healthy controls. Eur J
Neurosci. 28:389–398. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luijk MP, Velders FP, Tharner A, van
Ijzendoorn MH, Bakermans-Kranenburg MJ, Jaddoe VW, Hofman A,
Verhulst FC and Tiemeieret H: FKBP5 and resistant attachment
predict cortisol reactivity in infants: gene-environment
interaction. Psychoneuroendocrinology. 35:1454–1461. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sarginson JE, Lazzeroni LC, Ryan HS,
Schatzberg AF and Murphy GM Jr: FKBP5 polymorphisms and
antidepressant response in geriatric depression. Am J Med Genet B
Neuropsychiatr Genet. 153:554–560. 2010.PubMed/NCBI
|
|
24
|
Papiol S, Arias B, Gasto C, Gutierrez B,
Catalan R and Fananas L: Genetic variability at HPA axis in major
depression and clinical response to antidepressant treatment. J
Affect Disord. 104:83–90. 2007. View Article : Google Scholar : PubMed/NCBI
|
